Literature DB >> 19339488

Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients.

Inès Lakhal-Naouar1, Thouraya Boussoffara, Amel Meddeb-Garnaoui, Yosser Ben Achour-Chenik, Hechmi Louzir, Mehdi Chenik.   

Abstract

Cellular and humoral immune responses of healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients were evaluated against results for Leishmania major virulence proteins L. major protein disulfide isomerase (LmPDI) and mitogen-activated protein kinase kinase (MAPKK). Only MAPKK induces significant peripheral blood mononuclear cell proliferation with gamma interferon production as well as antibody responses. Thus, MAPKK may be of interest in Leishmania vaccination and serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339488      PMCID: PMC2691049          DOI: 10.1128/CVI.00023-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  15 in total

1.  Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis.

Authors:  Thouraya Bousoffara; Hechmi Louzir; Afif Ben Salah; Koussay Dellagi
Journal:  J Infect Dis       Date:  2004-03-12       Impact factor: 5.226

2.  Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal.

Authors:  François Chappuis; Suman Rijal; Uma Kant Jha; Philippe Desjeux; Bal Man Singh Karki; Shekhar Koirala; Louis Loutan; Marleen Boelaert
Journal:  Trop Med Int Health       Date:  2006-01       Impact factor: 2.622

3.  Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.

Authors:  Mahmoud R Jaafari; Attieh Ghafarian; Ahsan Farrokh-Gisour; Afshin Samiei; Masoumeh Tavassoti Kheiri; Fereidoun Mahboudi; Farzaneh Barkhordari; Ali Khamesipour; W Robert McMaster
Journal:  Vaccine       Date:  2006-05-11       Impact factor: 3.641

4.  Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.

Authors:  Naghmeh Khoshgoo; Farnaz Zahedifard; Hiva Azizi; Yasaman Taslimi; Maribel Jiménez Alonso; Sima Rafati
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

Review 5.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

6.  LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation.

Authors:  Daniela Kuhn; Martin Wiese
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

7.  Development and application of 'simple' diagnostic tools for visceral leishmaniasis.

Authors:  H D Schallig; G J Schoone; C C Kroon; A Hailu; F Chappuis; H Veeken
Journal:  Med Microbiol Immunol       Date:  2001-11       Impact factor: 3.402

Review 8.  Cutaneous leishmaniasis.

Authors:  Richard Reithinger; Jean-Claude Dujardin; Hechmi Louzir; Claude Pirmez; Bruce Alexander; Simon Brooker
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

9.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  4 in total

1.  A current perspective on leishmaniasis.

Authors:  Angela Clem
Journal:  J Glob Infect Dis       Date:  2010-05

2.  Mastomys natalensis Has a Cellular Immune Response Profile Distinct from Laboratory Mice.

Authors:  Tsing-Lee Tang-Huau; Kyle Rosenke; Kimberly Meade-White; Aaron Carmody; Brian J Smith; Catharine M Bosio; Michael A Jarvis; Heinz Feldmann
Journal:  Viruses       Date:  2021-04-22       Impact factor: 5.048

3.  Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.

Authors:  Rym Chamakh-Ayari; Mehdi Chenik; Ahmed Sahbi Chakroun; Narges Bahi-Jaber; Karim Aoun; Amel Meddeb-Garnaoui
Journal:  Parasit Vectors       Date:  2017-04-17       Impact factor: 3.876

4.  Elevated TGF-beta levels in drug-resistant visceral leishmaniasis.

Authors:  Miskelyemen A Elmekki; Mogahid M Elhassan; Hani A Ozbak; Moawia M Mukhtar
Journal:  Ann Saudi Med       Date:  2016 Jan-Feb       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.